Clinical Trials Directory

Trials / Completed

CompletedNCT02881996

The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis

Impact of IV Acetaminophen on Post-operative Pain After Laparoscopic Appendectomy for Perforated Appendicitis: A Prospective Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Children's Mercy Hospital Kansas City · Academic / Other
Sex
All
Age
2 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate two standard post-operative pain regimens routinely used after laparoscopic appendectomy for perforated appendicitis. The investigators hypothesize that the use of intravenous (IV) acetaminophen in addition to IV ketorolac with narcotic pain pump will decrease time to transition off patient/nurse controlled analgesia (PCA) to oral pain medications.

Detailed description

To assess pain control, patient and family perception of pain control, time to return of bowel function defined as passage of first flatus (in days), doses of anti-emetic medications, doses of narcotic pain medications, time to toleration of regular diet (in days), narcotic associated adverse effects (nausea, emesis, respiratory depression, constipation), length of stay, and overall hospital cost in admission. Post-hospitalization the investigators will assess complications including number and reasons for emergency visits and abscess formation, length of post-hospitalization analgesic use, length of post-hospitalization narcotic use, and time to return to school.

Conditions

Interventions

TypeNameDescription
DRUGIV tylenolIV tylenol given scheduled in addition to standard PCA
DRUGNo IV tylenolNo additional IV Tylenol given
DRUGKetorolacboth groups receive as part of our standard postop pain protocol after all operations

Timeline

Start date
2014-06-01
Primary completion
2016-06-01
Completion
2016-08-01
First posted
2016-08-29
Last updated
2021-01-12
Results posted
2021-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02881996. Inclusion in this directory is not an endorsement.